Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH)
(2023) reported that resistant rbohF and rbohD/F mutants infected by TuMV had increased activity of GST and GR, strongly downregulated GPXL, and highly reduced levels of lipid peroxidation
This system regulates disulfide bond formation, redox-sensitive transcription factors, and apoptosis
An increased risk for severe forms of COVID-19 was also reported in older individuals and patients with cardiovascular diseases and DCM [170, 171]
High-income countries (HICs) report higher prevalence rates due to better diagnostic tools, registry systems, and longer life expectancy
Statistics and reproducibility All statistical analyses were performed using SPSS 16.0